Somatostatin (SST)

Somatostatin (SST)

Introduction

Somatostatin (Sst) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@dvila2019]
<div class="infobox-header">Somatostatin</div> [@viollet2008]
<div class="infobox-row"><strong>Gene:</strong> [SST](/proteins/sst-protein)</div> [@moller2003]
<div class="infobox-row"><strong>UniProt ID:</strong> [P01274](https://www.uniprot.org/uniprot/P01274)</div> [@van2022]
<div class="infobox-row"><strong>PDB ID:</strong> [1OKH](https://www.rcsb.org/structure/1OKH)</div> [@epelbaum2022]
<div class="infobox-row"><strong>Molecular Weight:</strong> ~1.6 kDa (14 amino acids)</div>
<div class="infobox-row"><strong>Subcellular Localization:</strong> Secreted, dense-core vesicles</div>
<div class="infobox-row"><strong>Protein Family:</strong> Somatostatin family</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Acromegaly, Epilepsy</div>
</div>

Overview

Somatostatin (SST)

Introduction

Somatostatin (Sst) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@dvila2019]
<div class="infobox-header">Somatostatin</div> [@viollet2008]
<div class="infobox-row"><strong>Gene:</strong> [SST](/proteins/sst-protein)</div> [@moller2003]
<div class="infobox-row"><strong>UniProt ID:</strong> [P01274](https://www.uniprot.org/uniprot/P01274)</div> [@van2022]
<div class="infobox-row"><strong>PDB ID:</strong> [1OKH](https://www.rcsb.org/structure/1OKH)</div> [@epelbaum2022]
<div class="infobox-row"><strong>Molecular Weight:</strong> ~1.6 kDa (14 amino acids)</div>
<div class="infobox-row"><strong>Subcellular Localization:</strong> Secreted, dense-core vesicles</div>
<div class="infobox-row"><strong>Protein Family:</strong> Somatostatin family</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Acromegaly, Epilepsy</div>
</div>

Overview

Somatostatin (SST), also known as growth hormone-inhibiting hormone (GHIH), is a 14-amino acid cyclic peptide that functions as a universal inhibitor of hormone secretion and a key neuromodulator in the central nervous system[@patel1999]. Encoded by the SST gene, this peptide is produced in multiple forms—somatostatin-14 (predominant in the brain) and somatostatin-28 (predominant in the gut)—and signals through five somatostatin receptors (SSTR1-5) to regulate diverse physiological processes.

Structure

Somatostatin adopts a unique cyclic structure essential for its biological activity:

Primary Structure

• 14 amino acids: AGCKNFFWKTFTSC (disulfide bridge between C3-C14)
• Cyclic conformation through disulfide bond
• Essential bioactive sequence: FWKTF

Three-Dimensional Structure

• β-turn in center region
• Hydrophobic core
• Receptor binding requires intact cyclic structure
• Similar fold shared across species

Normal Function

Neuroendocrine Inhibition

• Growth hormone (GH) from anterior pituitary
• Thyroid-stimulating hormone (TSH)
• Insulin and glucagon from pancreas
• Gastrin and other GI hormones

Neuromodulation

• Inhibits neurotransmitter release (glutamate, acetylcholine)
• Reduces neuronal excitability
• Modulates synaptic plasticity
• Regulates cortical inhibition via SST+ interneurons

Cognitive Functions

• Learning and memory processes
• Attention and perception
• Gamma oscillation generation
• Cortical circuit computation

Receptor Interactions

Somatostatin signals through five G-protein coupled receptors (SSTR1-5), all Gi/o-coupled:

| Receptor | Primary Distribution | Key Functions |
|----------|---------------------|---------------|
| SSTR1 | [Cortex](/brain-regions/cortex), hippocampus | Anti-proliferative |
| SSTR2 | Cortex, pituitary | Cognitive effects |
| SSTR3 | Various | [Apoptosis](/entities/apoptosis), neuroprotection |
| SSTR4 | [Hippocampus](/brain-regions/hippocampus) | Memory |
| SSTR5 | Pituitary | Hormone regulation |

Signaling Pathways

• Inhibition of adenylate cyclase (↓cAMP)
• Activation of potassium channels
• Inhibition of voltage-gated calcium channels
• Activation of MAPK pathways

Disease Involvement

Alzheimer's Disease

• Cognitive decline severity
• Amyloid burden
• Network dysfunction

Parkinson's Disease

• Altered somatostatin receptor expression in PD brains
• Potential for motor and non-motor symptom modulation
• SST effects on dopaminergic neuron survival

Epilepsy

• Inhibits excitatory neurotransmission
• Reduces seizure spread
• SSTR2 agonists show antiepileptic potential

Acromegaly

Therapeutic Targeting

Clinical Somatostatin Analogs

Research Applications

• Neuroprotective strategies in AD
• Antiepileptic development
• Cognitive enhancement approaches

Research Directions

See Also

• [Proteins Index](/proteins)
• [SST Gene](/proteins/sst-protein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Cerebral Cortex](/brain-regions/cerebral-cortex)

External Links

• [UniProt: Somatostatin](https://www.uniprot.org/uniprot/P01274)
• [PDB: Somatostatin](https://www.rcsb.org/structure/1OKH)
• [IUPHAR: Somatostatin Receptors](https://www.guidetopharmacology.org/GRAC/ReceptorFamiliesForward?type=somatostatin)

Background

The study of Somatostatin (Sst) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Molecular Mechanisms

Somatostatin (SST) acts through five G protein-coupled receptor subtypes (SSTR1-5), with SSTR2 and SSTR5 being the most important for CNS effects. These receptors inhibit adenylate cyclase, reduce cAMP levels, and activate potassium channels, leading to neuronal hyperpolarization. Somatostatin is primarily produced by cortical interneurons, where it plays a critical role in regulating pyramidal neuron activity.

In the hippocampus, somatostatin-expressing interneurons target the perisomatic region of pyramidal cells, providing powerful inhibition that regulates network oscillations and memory consolidation. These neurons are distinct from parvalbumin and cholecystokinin-expressing interneurons, forming a unique inhibitory class.

Disease Associations

Alzheimer's Disease: Somatostatin levels are significantly reduced in Alzheimer's disease brains, particularly in the cortex and hippocampus. This deficit may contribute to hippocampal hyperactivity and seizure activity observed in some AD patients. Somatostatin also regulates amyloid-beta production and clearance, linking it directly to AD pathogenesis.

Parkinson's Disease: Somatostatin expression is altered in Parkinson's disease, with effects on motor control and non-motor symptoms. The peptide may modulate dopaminergic neuron survival and function.

Huntington's Disease: Somatostatin interneurons are relatively spared in Huntington's disease compared to other interneuron populations, making them a potential therapeutic target for cell replacement therapies.

Therapeutic Implications

Somatostatin analogs (octreotide, lanreotide) are used clinically for neuroendocrine tumors and have been explored for neurodegenerative applications. These compounds may help reduce excitotoxicity and modulate inflammatory responses in the brain.

Research Directions

Research is focused on understanding how somatostatin deficiency contributes to network dysfunction in AD and developing therapies that can restore somatostatin signaling. Novel SSTR subtype-selective agonists are being developed with improved brain penetration.

References